Patrick Aubonnet

Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study

Thomas Blevins, Abhijit Barve, Yaron Raiter et al. · Diabetes Obesity and Metabolism · 2019 · 33 citations · Full text

Effects of Fenofibric Acid on Diabetic Macular Edema: The MacuFen study

Pascale Massin, Tünde Pető, Jean-Claude Ansquer et al. · Ophthalmic Epidemiology · 2014 · 29 citations

Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study

Christopher Ll. Morgan, David R. Owens, Patrick Aubonnet et al. · BMJ Open · 2013 · 29 citations · Full text

Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study

Thomas Blevins, Abhijit Barve, Bin Sun et al. · Diabetes Obesity and Metabolism · 2018 · 28 citations · Full text

Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL‐1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitus

Tim Heise, Charles Donnelly, Abhijit Barve et al. · Diabetes Obesity and Metabolism · 2019 · 13 citations · Full text